Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 01, 2024, titled "Alembic Pharmaceuticals receives various US Food & Drug Administration (USFDA) product approvals (Tentative or Final) during the quarter ended 31st December, 2023.".